Cystic Fibrosis Research: Unraveling the Complexity | Painted Clothes

Cystic fibrosis research has made significant strides in recent years, with the discovery of the CFTR gene in 1989 by Francis Collins and Lap-Chee Tsui, and the development of treatments such as Kalydeco (ivacaftor) and Orkambi (lumacaftor/ivacaftor). However, the disease remains a major public health concern, affecting over 70,000 people worldwide, with a median survival age of around 44 years. Researchers like Dr. Bonnie Ramsey and Dr. Eric Accurso are working to improve our understanding of the disease, with a focus on gene therapy, gene editing, and personalized medicine. The Cystic Fibrosis Foundation has played a crucial role in funding research, with over $400 million invested in 2020 alone. Despite these efforts, controversy surrounds the high cost of treatments, with some medications priced over $300,000 per year, sparking debates about accessibility and affordability. As research continues to advance, the prospect of a cure or highly effective treatment is on the horizon, with some estimates suggesting that gene editing technologies like CRISPR could potentially cure the disease in the next decade.